Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens

Sanja Ivkovic, Christopher Beadle, Sonal Noticewala, Susan C. Massey, Kristin R. Swanson, Laura N. Toro, Anne R. Bresnick, Peter Canoll, Steven S. Rosenfeld

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Anaplastic gliomas, the most common and malignant of primary brain tumors, frequently contain activating mutations and amplifications in promigratory signal transduction pathways. However, targeting these pathways with individual signal transduction inhibitors does not appreciably reduce tumor invasion, because these pathways are redundant; blockade of any one pathway can be overcome by stimulation of another. This implies that a more effective approach would be to target a component at which these pathways converge. In this study, we have investigated whether the molecular motor myosin II represents such a target by examining glioma invasion in a series of increasingly complex models that are sensitive to platelet-derived growth factor, epidermal growth factor, or both. Our results lead to two conclusions. First, malignant glioma cells are stimulated to invade brain through the activation of multiple signaling cascades not accounted for in simple in vitro assays. Second, even though there is a high degree of redundancy in promigratory signaling cascades in gliomas, blocking tumor invasion by directly targeting myosin II remains effective. Our results thus support our hypothesis that myosin II represents a point of convergence for signal transduction pathways that drive glioma invasion and that its inhibition cannot be overcome by other motility mechanisms.

Original languageEnglish (US)
Pages (from-to)533-542
Number of pages10
JournalMolecular Biology of the Cell
Volume23
Issue number4
DOIs
StatePublished - Feb 15 2012

Fingerprint

Myosin Type II
Glioma
Signal Transduction
Platelet-Derived Growth Factor
Epidermal Growth Factor
Brain Neoplasms
Neoplasms
Mutation
Brain

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Ivkovic, S., Beadle, C., Noticewala, S., Massey, S. C., Swanson, K. R., Toro, L. N., ... Rosenfeld, S. S. (2012). Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens. Molecular Biology of the Cell, 23(4), 533-542. https://doi.org/10.1091/mbc.E11-01-0039

Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens. / Ivkovic, Sanja; Beadle, Christopher; Noticewala, Sonal; Massey, Susan C.; Swanson, Kristin R.; Toro, Laura N.; Bresnick, Anne R.; Canoll, Peter; Rosenfeld, Steven S.

In: Molecular Biology of the Cell, Vol. 23, No. 4, 15.02.2012, p. 533-542.

Research output: Contribution to journalArticle

Ivkovic, S, Beadle, C, Noticewala, S, Massey, SC, Swanson, KR, Toro, LN, Bresnick, AR, Canoll, P & Rosenfeld, SS 2012, 'Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens', Molecular Biology of the Cell, vol. 23, no. 4, pp. 533-542. https://doi.org/10.1091/mbc.E11-01-0039
Ivkovic, Sanja ; Beadle, Christopher ; Noticewala, Sonal ; Massey, Susan C. ; Swanson, Kristin R. ; Toro, Laura N. ; Bresnick, Anne R. ; Canoll, Peter ; Rosenfeld, Steven S. / Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens. In: Molecular Biology of the Cell. 2012 ; Vol. 23, No. 4. pp. 533-542.
@article{90a489fc9eed4649b8b31a54e23c841a,
title = "Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens",
abstract = "Anaplastic gliomas, the most common and malignant of primary brain tumors, frequently contain activating mutations and amplifications in promigratory signal transduction pathways. However, targeting these pathways with individual signal transduction inhibitors does not appreciably reduce tumor invasion, because these pathways are redundant; blockade of any one pathway can be overcome by stimulation of another. This implies that a more effective approach would be to target a component at which these pathways converge. In this study, we have investigated whether the molecular motor myosin II represents such a target by examining glioma invasion in a series of increasingly complex models that are sensitive to platelet-derived growth factor, epidermal growth factor, or both. Our results lead to two conclusions. First, malignant glioma cells are stimulated to invade brain through the activation of multiple signaling cascades not accounted for in simple in vitro assays. Second, even though there is a high degree of redundancy in promigratory signaling cascades in gliomas, blocking tumor invasion by directly targeting myosin II remains effective. Our results thus support our hypothesis that myosin II represents a point of convergence for signal transduction pathways that drive glioma invasion and that its inhibition cannot be overcome by other motility mechanisms.",
author = "Sanja Ivkovic and Christopher Beadle and Sonal Noticewala and Massey, {Susan C.} and Swanson, {Kristin R.} and Toro, {Laura N.} and Bresnick, {Anne R.} and Peter Canoll and Rosenfeld, {Steven S.}",
year = "2012",
month = "2",
day = "15",
doi = "10.1091/mbc.E11-01-0039",
language = "English (US)",
volume = "23",
pages = "533--542",
journal = "Molecular Biology of the Cell",
issn = "1059-1524",
publisher = "American Society for Cell Biology",
number = "4",

}

TY - JOUR

T1 - Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens

AU - Ivkovic, Sanja

AU - Beadle, Christopher

AU - Noticewala, Sonal

AU - Massey, Susan C.

AU - Swanson, Kristin R.

AU - Toro, Laura N.

AU - Bresnick, Anne R.

AU - Canoll, Peter

AU - Rosenfeld, Steven S.

PY - 2012/2/15

Y1 - 2012/2/15

N2 - Anaplastic gliomas, the most common and malignant of primary brain tumors, frequently contain activating mutations and amplifications in promigratory signal transduction pathways. However, targeting these pathways with individual signal transduction inhibitors does not appreciably reduce tumor invasion, because these pathways are redundant; blockade of any one pathway can be overcome by stimulation of another. This implies that a more effective approach would be to target a component at which these pathways converge. In this study, we have investigated whether the molecular motor myosin II represents such a target by examining glioma invasion in a series of increasingly complex models that are sensitive to platelet-derived growth factor, epidermal growth factor, or both. Our results lead to two conclusions. First, malignant glioma cells are stimulated to invade brain through the activation of multiple signaling cascades not accounted for in simple in vitro assays. Second, even though there is a high degree of redundancy in promigratory signaling cascades in gliomas, blocking tumor invasion by directly targeting myosin II remains effective. Our results thus support our hypothesis that myosin II represents a point of convergence for signal transduction pathways that drive glioma invasion and that its inhibition cannot be overcome by other motility mechanisms.

AB - Anaplastic gliomas, the most common and malignant of primary brain tumors, frequently contain activating mutations and amplifications in promigratory signal transduction pathways. However, targeting these pathways with individual signal transduction inhibitors does not appreciably reduce tumor invasion, because these pathways are redundant; blockade of any one pathway can be overcome by stimulation of another. This implies that a more effective approach would be to target a component at which these pathways converge. In this study, we have investigated whether the molecular motor myosin II represents such a target by examining glioma invasion in a series of increasingly complex models that are sensitive to platelet-derived growth factor, epidermal growth factor, or both. Our results lead to two conclusions. First, malignant glioma cells are stimulated to invade brain through the activation of multiple signaling cascades not accounted for in simple in vitro assays. Second, even though there is a high degree of redundancy in promigratory signaling cascades in gliomas, blocking tumor invasion by directly targeting myosin II remains effective. Our results thus support our hypothesis that myosin II represents a point of convergence for signal transduction pathways that drive glioma invasion and that its inhibition cannot be overcome by other motility mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=84857198896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857198896&partnerID=8YFLogxK

U2 - 10.1091/mbc.E11-01-0039

DO - 10.1091/mbc.E11-01-0039

M3 - Article

VL - 23

SP - 533

EP - 542

JO - Molecular Biology of the Cell

JF - Molecular Biology of the Cell

SN - 1059-1524

IS - 4

ER -